These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 15252205)

  • 1. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
    Yao D; Gu Z; Nakamura T; Shi ZQ; Ma Y; Gaston B; Palmer LA; Rockenstein EM; Zhang Z; Masliah E; Uehara T; Lipton SA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10810-4. PubMed ID: 15252205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function.
    Chung KK; Thomas B; Li X; Pletnikova O; Troncoso JC; Marsh L; Dawson VL; Dawson TM
    Science; 2004 May; 304(5675):1328-31. PubMed ID: 15105460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
    Ko HS; Lee Y; Shin JH; Karuppagounder SS; Gadad BS; Koleske AJ; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16691-6. PubMed ID: 20823226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin and defective ubiquitination in Parkinson's disease.
    Dawson TM
    J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoregulation of Parkin activity through its ubiquitin-like domain.
    Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
    EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
    Im E; Yoo L; Hyun M; Shin WH; Chung KC
    Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.
    Kurup PK; Xu J; Videira RA; Ononenyi C; Baltazar G; Lombroso PJ; Nairn AC
    Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1202-7. PubMed ID: 25583483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do Parkin mutations result in neurodegeneration?
    Imai Y; Takahashi R
    Curr Opin Neurobiol; 2004 Jun; 14(3):384-9. PubMed ID: 15194120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
    Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
    Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination.
    Trempe JF; Chen CX; Grenier K; Camacho EM; Kozlov G; McPherson PS; Gehring K; Fon EA
    Mol Cell; 2009 Dec; 36(6):1034-47. PubMed ID: 20064468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neddylation positively regulates the ubiquitin E3 ligase activity of parkin.
    Um JW; Han KA; Im E; Oh Y; Lee K; Chung KC
    J Neurosci Res; 2012 May; 90(5):1030-42. PubMed ID: 22271254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease state mutation unfolds the parkin ubiquitin-like domain.
    Safadi SS; Shaw GS
    Biochemistry; 2007 Dec; 46(49):14162-9. PubMed ID: 18004887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
    Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
    J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin is linked to the ubiquitin pathway.
    Tanaka K; Suzuki T; Chiba T; Shimura H; Hattori N; Mizuno Y
    J Mol Med (Berl); 2001 Sep; 79(9):482-94. PubMed ID: 11692161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin.
    Ardley HC; Scott GB; Rose SA; Tan NG; Markham AF; Robinson PA
    Mol Biol Cell; 2003 Nov; 14(11):4541-56. PubMed ID: 12937272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.